<p>Aptus Pharma Limited will hold a board meeting on Tuesday, October 20, 2026, to consider and approve the unaudited financial results for the half year ended September 30, 2026, and to take on record the limited review report thereon; the trading window for the company's securities has been closed from October 1, 2026, and will remain closed until 48 hours after the declaration of the financial results.</p>